In conclusion, important findings of this current study were that β-glucan might intervention alleviated intestinal inflammation through the TLR4-NF-κB pathway, improved gut barrier, and partially modulated gut microbiota, ultimately protected against NEC in a mouse model. The gene discussed is TLR4; the disease is necrotizing enterocolitis.